IRLAB Therapeutics AB
STO:IRLAB A

Watchlist Manager
IRLAB Therapeutics AB Logo
IRLAB Therapeutics AB
STO:IRLAB A
Watchlist
Price: 12.6 SEK -1.95%
Market Cap: 652.5m SEK
Have any thoughts about
IRLAB Therapeutics AB?
Write Note

IRLAB Therapeutics AB
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

IRLAB Therapeutics AB
Cash Equivalents Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
MOB
I
FLERIE

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
IRLAB Therapeutics AB
STO:IRLAB A
Cash Equivalents
kr111.3m
CAGR 3-Years
-26%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Cash Equivalents
kr2.6B
CAGR 3-Years
83%
CAGR 5-Years
55%
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Cash Equivalents
kr170m
CAGR 3-Years
-49%
CAGR 5-Years
34%
CAGR 10-Years
N/A
Moberg Pharma AB (publ)
STO:MOB
Cash Equivalents
kr60.6m
CAGR 3-Years
46%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Cash Equivalents
kr882.2m
CAGR 3-Years
23%
CAGR 5-Years
77%
CAGR 10-Years
N/A

See Also

What is IRLAB Therapeutics AB's Cash Equivalents?
Cash Equivalents
111.3m SEK

Based on the financial report for Dec 31, 2023, IRLAB Therapeutics AB's Cash Equivalents amounts to 111.3m SEK.

What is IRLAB Therapeutics AB's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
-4%

Over the last year, the Cash Equivalents growth was -56%. The average annual Cash Equivalents growth rates for IRLAB Therapeutics AB have been -26% over the past three years , -4% over the past five years .

Back to Top